A review of the short, intermediate, and long-term complications following treatment for both nonmuscle-invasive and muscle-invasive urothelial carcinoma of the bladder are presented. Additionally, the lecture offers practical suggestions for management of these complications.
Contact hours available until 2/28/17.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures: Christine Bradway, PhD, RN, CRNP: Consultant/Presenter Bureau: Direct Supply Inc. and Advisory Board: Astelles
Cheryl A. LeCroy, MSN, RN: Consultant: Allergan
Speaker Disclosures: There are no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Recognize risks of treatment for NMIBC.
Recognize risks of treatment for MIBC.
Describe management principles of complications following treatment for NMIBC and MIBC.